Parvovirus B19 infection can cause a wide spectrum of disease syndromes. Two cases of parvovirus B19 infection were identified that resulted in life-threatening myocarditis shortly after acute infection in immunocompetent individuals. The diagnosis was made with serological and polymerase chain reaction techniques. One patient was succesfully treated by heart transplantation. Sequence analysis showed that the parvovirus B19 cloned from the patients' sera had 99% homology with the prototype sequence. Clinicians should be alerted to the possible role of parvovirus B19 in myocarditis presenting in immunocompetent patients.
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Polymerase Chain Reaction
There is an expanding spectrum of clinical disease attributed to human parvovirus B19 infection [1] . Myocarditis brought PCR analysis was performed by a single-round PCR ampliabout by this virus has been reported following infection in fication reaction that coamplifies VP1 and VP2 sequences in utero [2] . There has also been a report of myocarditis associated a single step using the following primers: VP1 5 AGG AAG with parvovirus B19 infection in an infant [3] and one of TTT GCC GGA AGT TC 3 and 5 GTG CTG AAA CTC transitory heart failure in a thalassemic adult [4] . As yet, no curative treatment for life-threatening parvovirus B19 -associ-TAA AGG TG 3; VP2 5 GAC ATG GAT ATG AAA AGC ated disease has been proposed. We report here two cases CTG AAG 3 and 5 GTT GTT CAT ATC TGG TTA AGT of parvovirus B19 infection that were associated with life-ACT 3. Semiquantitative evaluation of the viral load was perthreatening myocarditis, one of which was successfully treated formed with use of serial dilutions of the specimens and a DNA by heart transplantation.
preparation of a parvovirus B19 full-length clone of known concentration (10 fg of the clone represents Ç100 B19 genome copies). Nucleic acid was extracted from body fluids with the
Materials and Methods
QIAmp Blood Kit (QIAGEN, Hilden, Germany) and from bi- and subsequent PCR steps [7] .
/ 9c46$$fe06 01-08-98 22:46:10 cidas UC: CID for independent analysis. The serological results were conted in April 1994 following progressive fatigue over a period firmed by a parvovirus B19 IgG antibody assay (DAKO) and of 2 weeks and syncope associated with congestive heart failure an in-house monoclonal antibody capture radioimmunoassay with tachycardia (160 beats/min), tachypnea, hepatomegaly, for IgM. Parvovirus B19 DNA could also be detected in the and radiographic cardiomegaly. In addition, severe abdominal biopsy specimens by single-round and nested PCR methods. spasms and diarrhea occurred that did not respond to treatment.
Microscopic analysis of the removed heart revealed hypotroElectrocardiography showed T-wave inversion and elevated phic heart-muscle tissue with enlarged and irregular nuclei, S-T segments. The left ventricle was dilated and contracted particularly in the region of the left ventricle. The interstitium poorly.
had many fibrous dilations and contained discrete lymphocytic Laboratory analysis revealed a hemoglobin level of 14.6
infiltrations. The rear wall had a transmural scar. Analysis of g/dL, C-reactive protein level of 171 mg/L, and a leukocyte the other sections revealed fine, netlike fibrosis of varying decount of 11,000/mm 3 . The intravenous administration of diuretgrees with discrete lymphocytic infiltration in places. In addiics, catecholamines, and inodilators did not stabilize the pation, mild endocarditic fibrosis as well as slight chronic and tient's condition. The patient therefore underwent orthotopic fibrous pericarditis were evident in papillary muscle close to cardiac transplantation 2 months after admission and recovered the scar. The findings were considered to be in accordance well. More than 2 years later, in March 1997, the patient was with an almost completely healed perimyocarditis. reported to be in excellent health.
Patient 2. In April 1995 a 7-year-old girl was admitted to Before admission, the patient had had no typical clinical the hospital because of a 5-day history of high fever, vomiting, symptoms of parvovirus B19 infection. A serum sample was and joint and abdominal pain. She also had a truncal rash taken shortly after admission in order to search for an infectious with erythematous macules on the abdomen and upper chest, cause of disease. The serological findings, which were as folpurpuric lesions on the back, and urticarial lesions on the flexor lows, showed no indication of infection with the infectious surfaces of both arms. On admission the child was severely ill agents tested: enterovirus (coxsackievirus and echovirus pool with a fever (temperature, 40.2ЊC), pulse rate of 120/min, blood antigen) CF test (CFT), 1 , a hemato-EIA, IgG of õ2 IU/mL and IgM of õ1.0. Nonetheless, parvocrit of 37.1%, a C-reactive protein level of 3.1 mg/dL, and a virus B19 DNA was detected in this serum by PCR. A sample hemoglobin level of 11.8 g/dL. Blood gas analysis was normal, drawn 3 weeks later revealed seroconversion for IgG and IgM and blood and urine cultures were negative. Cardiac arrest antibodies to parvovirus B19. The serological findings with occurred suddenly on the 7th day of illness; resuscitation efforts regard to all the other infectious agents corresponded to those (intubation, ventilation, i.v. catecholamine and adrenaline, and found in the first serum sample.
electrical and manual stimulation of the heart) were successful Parvovirus B19 DNA was also detected in numerous biopsy specimens of the patient's removed heart (table 1). Serum samonly for a short time, and the patient died after 45 minutes.
/ 9c46$$fe06 01-08-98 22:46:10 cidas UC: CID Serological analysis of sera collected on the 4th and 7th days ever, parvovirus B19 infection runs a subclinical course or produces only mild symptoms. of illness showed no evidence of recent infection with the following viruses: enteroviruses (per CFT using enterovirus
The mechanisms influencing the severity of infection are as yet poorly understood. One possibility may be the existence pool antigen as well as individual antigens of coxsackieviruses B1 -5, echoviruses 11 and 30, and coxsackieviruses A5, 7, 9, of particularly virulent parvovirus B19 strains. However, nucleotide sequence analysis of parvovirus B19 DNA (ú2,000 nt 10, and 16; and in-house EIAs for IgM and IgA using coxsackie-echovirus pool antigen), herpes simplex, varicella zosfrom case 1 and ú600 nt from case 2), which was cloned from the patients' sera, showed 99% homology with the published ter, cytomegalovirus, measles, rubella, mumps, influenza A and B, and parainfluenza. However, acute infection with parvovirus sequence [9] , which argues against strain variation. The cellular receptor for parvovirus B19, blood group P antigen or globo-B19 was demonstrated in two independent laboratories by the presence of parvovirus B19 -specific IgG and IgM antibodies side, is known to be present on fetal cardiac myocytes [10] . This is consistent with evidence that parvovirus B19 -infected and by the detection of parvovirus B19 DNA by PCR in both serum samples. Parvovirus B19 DNA was also detected in fetuses can develop myocarditis [2] . Myocarditis in the individuals described herein may have been partly due to persistence ascites and pericardial fluid, as well as in lung and heart muscle (table 2). Attempts to isolate virus in cell culture of ascites, of P antigen on myocardial cells. The clinician should be aware of the possible role of parvovipericardial fluid, and lung tissue were unsuccessful, and detection of enterovirus RNA by PCR was also negative [8] .
rus B19 in myocarditis presenting in immunocompetent patients. In cases of life-threatening disease, cardiac transplantaHistology of the heart revealed diffuse lymphocytic infiltration in all sections but particularly around the right ventricle, tion can provide an adequate form of treatment, as seen here in patient 1. However, even if a suitable donor heart had been as well as cardiomyocytes with enlarged nuclei. In addition, fresh parenchymal bleeding was seen that may have resulted available, transplantation probably would not have saved the life of patient 2. The intravenous administration of immune from resuscitation attempts. globulin (IVIG) has been proposed as a treatment for severe persisting anemia associated with parvovirus B19 infection in immunocompromised individuals. However, the patients deDiscussion scribed herein were able to mount a satisfactory immune reThe patients described herein suffered severe myocarditis sponse, as demonstrated by the increase in both IgG and IgM following acute parvovirus B19 infection. Although neither antibodies. patient was known to have been in contact with the virus, both
Although we consider it unlikely that IVIG would have were infected in the month of April, when parvovirus B19 helped the patients described herein, who suffered acute rather infections are prevalent. Infections with enteroviruses, which than chronic parvovirus B19 infection, it may benefit patients are frequently associated with myocarditis, tend to occur in the with parvovirus-associated myocarditis who are immunocomlate summer months and were not prevalent in the patients'
promised. The role of parvovirus B19 in both fetal and childcommunities at the time.
hood myocarditis warrants further studies. Taken together, these two cases provide convincing evidence of the involvement of parvovirus B19 in cardiac disease. Re-
